Medpace (MEDP) Competitors $323.50 -4.74 (-1.44%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$323.69 +0.19 (+0.06%) As of 07/11/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEDP vs. ICLR, EHC, ELV, HIMS, IQV, RDDT, CPAY, GIB, TOST, and AERShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Icon (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Reddit (RDDT), Corpay (CPAY), CGI Group (GIB), Toast (TOST), and Aercap (AER). Medpace vs. Its Competitors Icon Encompass Health Elevance Health Hims & Hers Health IQVIA Reddit Corpay CGI Group Toast Aercap Icon (NASDAQ:ICLR) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations. Do analysts recommend ICLR or MEDP? Icon currently has a consensus target price of $198.08, suggesting a potential upside of 31.60%. Medpace has a consensus target price of $344.82, suggesting a potential upside of 6.59%. Given Icon's stronger consensus rating and higher possible upside, research analysts clearly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.60Medpace 0 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.21 Is ICLR or MEDP more profitable? Medpace has a net margin of 19.31% compared to Icon's net margin of 9.25%. Medpace's return on equity of 54.36% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.25% 11.46% 6.49% Medpace 19.31%54.36%20.81% Do institutionals & insiders hold more shares of ICLR or MEDP? 95.6% of Icon shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 44.0% of Icon shares are owned by insiders. Comparatively, 20.3% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, ICLR or MEDP? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.19B1.48$791.47M$9.1816.40Medpace$2.11B4.41$404.39M$13.1024.69 Does the media favor ICLR or MEDP? In the previous week, Medpace had 6 more articles in the media than Icon. MarketBeat recorded 20 mentions for Medpace and 14 mentions for Icon. Medpace's average media sentiment score of 0.96 beat Icon's score of 0.75 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ICLR or MEDP? Icon has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.30B$7.32B$5.55B$9.09BDividend YieldN/A2.84%5.25%4.02%P/E Ratio24.6934.5428.2620.27Price / Sales4.4135.94408.79151.98Price / Cash23.1923.1337.1257.67Price / Book12.186.858.045.49Net Income$404.39M$236.02M$3.19B$250.45M7 Day Performance0.62%0.01%3.62%4.79%1 Month Performance8.47%2.76%5.98%9.59%1 Year Performance-26.98%33.80%29.39%16.41% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.2707 of 5 stars$323.50-1.4%$344.82+6.6%-27.0%$9.30B$2.11B24.695,900News CoverageAnalyst RevisionICLRIcon4.4658 of 5 stars$147.59-1.7%$213.08+44.4%-55.2%$11.92B$8.19B16.0841,900News CoverageAnalyst ForecastAnalyst RevisionGap DownEHCEncompass Health4.9257 of 5 stars$119.22+0.2%$127.00+6.5%+36.9%$12.02B$5.37B24.6340,000News CoverageAnalyst RevisionELVElevance Health4.9595 of 5 stars$346.76-0.3%$498.87+43.9%-36.6%$78.34B$177.01B13.53104,200Trending NewsUpcoming EarningsAnalyst ForecastHIMSHims & Hers Health2.0809 of 5 stars$48.34+0.8%$39.58-18.1%+120.7%$10.82B$1.78B70.061,637Trending NewsAnalyst DowngradeInsider TradeIQVIQVIA4.9295 of 5 stars$162.57-1.0%$226.32+39.2%-27.4%$28.12B$15.41B22.1588,000News CoverageAnalyst ForecastAnalyst RevisionRDDTReddit2.1687 of 5 stars$153.50-2.2%$139.70-9.0%+97.5%$28.32B$1.30B260.172,233Trending NewsAnalyst ForecastCPAYCorpay3.7528 of 5 stars$332.26-2.0%$401.86+20.9%+13.2%$23.42B$3.97B23.3011,200Positive NewsAnalyst DowngradeGIBCGI Group4.2369 of 5 stars$104.34-1.7%$156.75+50.2%-5.0%$23.41B$10.79B19.0190,250News CoveragePositive NewsTOSTToast2.4336 of 5 stars$44.83+2.9%$41.21-8.1%+72.2%$22.33B$5.22B194.915,700Options VolumeAERAercap2.294 of 5 stars$116.37+0.4%$119.25+2.5%+19.4%$21.74B$8.00B10.33740Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Icon Alternatives Encompass Health Alternatives Elevance Health Alternatives Hims & Hers Health Alternatives IQVIA Alternatives Reddit Alternatives Corpay Alternatives CGI Group Alternatives Toast Alternatives Aercap Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDP) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDP Stock Alerts